Share chart AbCellera Biologics Inc.
Extended chart
Simple chart
About AbCellera Biologics Inc.
AbCellera Biologics Inc. разрабатывает платформу для обнаружения антител. Его полнофункциональная платформа для поиска лекарств на базе искусственного интеллекта ищет и анализирует базу данных естественных иммунных систем, чтобы найти антитела, которые можно разработать в качестве лекарств. Компания также разрабатывает трансгенных мышей следующего поколения, которые являются источником полностью человеческих антител для открытия терапевтических кандидатов в антитела. У него есть соглашение о партнерстве с Eli Lilly and Company для обнаружения различных объектов. AbCellera Biologics Inc. more details| IPO date | 2020-12-11 |
|---|---|
| ISIN | CA00288U1066 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.abcellera.com |
| Цена ао | 2.53 |
| Change price per day: | 0% (2.53) |
|---|---|
| Change price per week: | +5.86% (2.39) |
| Change price per month: | -15.38% (2.99) |
| Change price per 3 month: | -14.24% (2.95) |
| Change price per half year: | -1.17% (2.56) |
| Change price per year: | -43.65% (4.49) |
| Change price per 3 year: | -70.09% (8.46) |
| Change price per year to date: | -16.5% (3.03) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Baillie Gifford and Company | 24044796 | 8.21 |
| Baker Brothers Advisors, LLC | 22909753 | 7.82 |
| Voya Investment Management LLC | 10624185 | 3.63 |
| Capital World Investors | 8351293 | 2.85 |
| Credit Suisse Ag/ | 4578250 | 1.56 |
| Orbimed Advisors LLC. | 4180768 | 1.43 |
| ArrowMark Colorado Holdings LLC | 4105095 | 1.4 |
| Blackrock Inc. | 3905713 | 1.33 |
| Founders Fund VII Management, LLC | 3773530 | 1.29 |
| Lazard Asset Management LLC | 3412005 | 1.17 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| TrueShares Technology, AI & Deep Learning ETF | 0.75121 | 24.67 | 0.0924 |
| Virtus LifeSci Biotech Clinical Trials ETF | 0.61598 | 63.04 | 0.33 |
| Invesco Nasdaq Biotechnology ETF | 0.07764 | 28.58 | 0.8565 |
| Future Tech ETF | 0.07508 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.07508 | 618.5 | 0.8416 |
| SPDR S&P International Small Cap ETF | 0.05771 | 8.94 | 3.10348 |
| ProShares Ultra Nasdaq Biotechnology | 0.05374 | 51.7 | 0.85651 |
| Avantis U.S Small Cap Equity ETF | 0.00885 | 27.77 | 1.68271 |
| Avantis U.S. Equity ETF | 0.00245 | 23.04 | 1.59151 |
SPDR Portfolio Developed World ex-US ETF
|
0.00199 | 5.29 | 3.28401 |
| 0.17 | 127.79 | 1.35 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Veronique Lecault Ph.D. | COO & Director | 645.07k | 1985 (40 years) |
| Dr. Ester Falconer Ph.D. | Chief Technology Officer | N/A | 1975 (50 years) |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer | 642.42k | 1974 (51 year) |
| Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson | 711.47k | 1975 (50 years) |
| Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting | N/A | |
| Graham Craig M.Sc. | Director of Corporate Development | N/A | |
| Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer | 644.4k | 1970 (55 years) |
| Mr. Neil Aubuchon B.A., M.B.A. | Chief Commercial Officer | 684.81k | 1970 (55 years) |
| Kathleen Reid B.A. | Head of Corporate Communications | N/A | |
| Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering | N/A |
Address: Canada, Vancouver, BC VY A, 2215 Yukon Street - open in Google maps, open in Yandex maps
Website: http://www.abcellera.com
Website: http://www.abcellera.com
